TY - JOUR
T1 - DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis
AU - Engal, Eden
AU - Sharma, Aveksha
AU - Aviel, Uria
AU - Taqatqa, Nadeen
AU - Juster, Sarah
AU - Jaffe-Herman, Shiri
AU - Bentata, Mercedes
AU - Geminder, Ophir
AU - Gershon, Adi
AU - Lewis, Reyut
AU - Kay, Gillian
AU - Hecht, Merav
AU - Epsztejn-Litman, Silvina
AU - Gotkine, Marc
AU - Mouly, Vincent
AU - Eiges, Rachel
AU - Salton, Maayan
AU - Drier, Yotam
N1 - Publisher Copyright:
Copyright © 2024 the Authors, some rights reserved.
PY - 2024/5
Y1 - 2024/5
N2 - Structural maintenance of chromosomes flexible hinge domain-containing 1 (SMCHD1) is a noncanonical SMC protein and an epigenetic regulator. Mutations in SMCHD1 cause facioscapulohumeral muscular dystrophy (FSHD), by overexpressing DUX4 in muscle cells. Here, we demonstrate that SMCHD1 is a key regulator of alternative splicing in various cell types. We show how SMCHD1 loss causes splicing alterations of DNMT3B, which can lead to hypomethylation and DUX4 overexpression. Analyzing RNA sequencing data from muscle biopsies of patients with FSHD and Smchd1 knocked out cells, we found mis-splicing of hundreds of genes upon SMCHD1 loss. We conducted a high-throughput screen of splicing factors, revealing the involvement of the splicing factor RBM5 in the mis-splicing of DNMT3B. Subsequent RNA immunoprecipitation experiments confirmed that SMCHD1 is required for RBM5 recruitment. Last, we show that mis-splicing of DNMT3B leads to hypomethylation of the D4Z4 region and to DUX4 overexpression. These results suggest that DNMT3B mis-splicing due to SMCHD1 loss plays a major role in FSHD pathogenesis.
AB - Structural maintenance of chromosomes flexible hinge domain-containing 1 (SMCHD1) is a noncanonical SMC protein and an epigenetic regulator. Mutations in SMCHD1 cause facioscapulohumeral muscular dystrophy (FSHD), by overexpressing DUX4 in muscle cells. Here, we demonstrate that SMCHD1 is a key regulator of alternative splicing in various cell types. We show how SMCHD1 loss causes splicing alterations of DNMT3B, which can lead to hypomethylation and DUX4 overexpression. Analyzing RNA sequencing data from muscle biopsies of patients with FSHD and Smchd1 knocked out cells, we found mis-splicing of hundreds of genes upon SMCHD1 loss. We conducted a high-throughput screen of splicing factors, revealing the involvement of the splicing factor RBM5 in the mis-splicing of DNMT3B. Subsequent RNA immunoprecipitation experiments confirmed that SMCHD1 is required for RBM5 recruitment. Last, we show that mis-splicing of DNMT3B leads to hypomethylation of the D4Z4 region and to DUX4 overexpression. These results suggest that DNMT3B mis-splicing due to SMCHD1 loss plays a major role in FSHD pathogenesis.
UR - http://www.scopus.com/inward/record.url?scp=85194895616&partnerID=8YFLogxK
U2 - 10.1126/sciadv.adn7732
DO - 10.1126/sciadv.adn7732
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38809976
AN - SCOPUS:85194895616
SN - 2375-2548
VL - 10
JO - Science advances
JF - Science advances
IS - 22
M1 - eadn7732
ER -